Search research articles
Contact Us
Filters
Showing results (41-50 of 44) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 44 results.
Journal of the International AIDS Society
|
August 4, 2017
High rates of viral suppression in adults and children with high CD4+ counts using a streamlined ART delivery model in the SEARCH trial in rural Uganda and Kenya
Dalsone Kwarisiima, Moses R Kamya, Asiphas Owaraganise, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 10, 2018
Early Adopters of Human Immunodeficiency Virus Preexposure Prophylaxis in a Population-based Combination Prevention Study in Rural Kenya and Uganda
Catherine A Koss, James Ayieko, Florence Mwangwa, et al.
The Lancet. HIV
|
April 30, 2022
Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1-2 trial
Theodore D Ruel, Edward P Acosta, Jessica P Liu, et al.
The Lancet. HIV
|
February 23, 2020
Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study
Catherine A Koss, Edwin D Charlebois, James Ayieko, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 44) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 44 results.
Journal of the International AIDS Society
|
August 4, 2017
High rates of viral suppression in adults and children with high CD4+ counts using a streamlined ART delivery model in the SEARCH trial in rural Uganda and Kenya
Dalsone Kwarisiima, Moses R Kamya, Asiphas Owaraganise, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
May 10, 2018
Early Adopters of Human Immunodeficiency Virus Preexposure Prophylaxis in a Population-based Combination Prevention Study in Rural Kenya and Uganda
Catherine A Koss, James Ayieko, Florence Mwangwa, et al.
The Lancet. HIV
|
April 30, 2022
Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1-2 trial
Theodore D Ruel, Edward P Acosta, Jessica P Liu, et al.
The Lancet. HIV
|
February 23, 2020
Uptake, engagement, and adherence to pre-exposure prophylaxis offered after population HIV testing in rural Kenya and Uganda: 72-week interim analysis of observational data from the SEARCH study
Catherine A Koss, Edwin D Charlebois, James Ayieko, et al.
Page
of 5